The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

Bruno François; Jean Chastre; Philippe Eggiman; Pierre-François Laterre; Antoni Torres; Miguel Sanchez; Mark T Esser; Brian Bishop; Marc Bonten; Herman Goosens; Hasan S Jafri

doi:10.1093/cid/ciw245

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

Bruno François, Jean Chastre, Philippe Eggiman, Pierre-François Laterre, Antoni Torres, Miguel Sanchez, Mark T Esser, Brian Bishop, Marc Bonten, Herman Goosens, Hasan S Jafri

Research output: Contribution to journal › Article › Academic › peer-review

1 Downloads (Pure)

Abstract

The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.

Original language	English
Pages (from-to)	S46-S51
Journal	Clinical Infectious Diseases
Volume	63
Issue number	Suppl 2
DOIs	https://doi.org/10.1093/cid/ciw245
Publication status	Published - 15 Aug 2016

Keywords

nosocomial pneumonia
ventilator-associated pneumonia
monoclonal antibody
ICU

Access to Document

10.1093/cid/ciw245

51Final published version, 191 KB

Fingerprint

Dive into the research topics of 'The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia'. Together they form a unique fingerprint.

Cite this

François, B., Chastre, J., Eggiman, P., Laterre, P.-F., Torres, A., Sanchez, M., Esser, M. T., Bishop, B., Bonten, M., Goosens, H., & Jafri, H. S. (2016). The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia. Clinical Infectious Diseases, 63 (Suppl 2), S46-S51. https://doi.org/10.1093/cid/ciw245

@article{e2d965b34f4441a58a21b648eb5e100e,

title = "The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia",

abstract = "The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.",

keywords = "nosocomial pneumonia, ventilator-associated pneumonia, monoclonal antibody, ICU",

author = "Bruno Fran{\c c}ois and Jean Chastre and Philippe Eggiman and Pierre-Fran{\c c}ois Laterre and Antoni Torres and Miguel Sanchez and Esser, {Mark T} and Brian Bishop and Marc Bonten and Herman Goosens and Jafri, {Hasan S}",

year = "2016",

month = aug,

day = "15",

doi = "10.1093/cid/ciw245",

language = "English",

volume = "63 ",

pages = "S46--S51",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "Suppl 2",

}

François, B, Chastre, J, Eggiman, P, Laterre, P-F, Torres, A, Sanchez, M, Esser, MT, Bishop, B, Bonten, M, Goosens, H & Jafri, HS 2016, 'The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia', Clinical Infectious Diseases, vol. 63 , no. Suppl 2, pp. S46-S51. https://doi.org/10.1093/cid/ciw245

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia. / François, Bruno; Chastre, Jean; Eggiman, Philippe et al.
In: Clinical Infectious Diseases, Vol. 63 , No. Suppl 2, 15.08.2016, p. S46-S51.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium

T2 - A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

AU - François, Bruno

AU - Chastre, Jean

AU - Eggiman, Philippe

AU - Laterre, Pierre-François

AU - Torres, Antoni

AU - Sanchez, Miguel

AU - Esser, Mark T

AU - Bishop, Brian

AU - Bonten, Marc

AU - Goosens, Herman

AU - Jafri, Hasan S

PY - 2016/8/15

Y1 - 2016/8/15

N2 - The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.

AB - The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.

KW - nosocomial pneumonia

KW - ventilator-associated pneumonia

KW - monoclonal antibody

KW - ICU

U2 - 10.1093/cid/ciw245

DO - 10.1093/cid/ciw245

M3 - Article

C2 - 27481953

SN - 1058-4838

VL - 63

SP - S46-S51

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - Suppl 2

ER -

François B, Chastre J, Eggiman P, Laterre PF, Torres A, Sanchez M et al. The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia. Clinical Infectious Diseases. 2016 Aug 15;63 (Suppl 2):S46-S51. doi: 10.1093/cid/ciw245